Health Care & Hospital Law,
Civil Litigation
Mar. 16, 2021
Opioid makers must face trial on deception allegations, judge rules
The plaintiffs, representing California cities and counties, seek a court order declaring the companies have engaged in unlawful, unfair and deceptive business practices to drive up drug sales in California while trivializing the risk of misuse and addiction.
Several major opioid manufacturers must stand trial on allegations they engaged in a sophisticated and deceptive marketing campaign to promote prescription opioids by overstating their benefits while downplaying risks, leading to an explosion of prescriptions and widespread addiction, an Orange County Superior Court judge ruled.
The plaintiffs seek a court order declaring the companies have engaged in unlawful, unfair and deceptive...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Civil Litigation
Does state’s opioid deal cut off others ‘at the knees’?
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Opioid makers argue for separate consideration in trial
By Blaise Scemama
Health Care & Hospital Law
Drug company lawyers grill historian in opioid trial
By Blaise Scemama
Government, Criminal
San Francisco public defender opposes DA’s fentanyl task force
By Tyler Pialet
